Bicycle Therapeutics Plc ADR (BCYC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Sales | 10,390 | 13,801 | 7,136 | 2,060 | 0 |
| Gross Profit | 10,390 | 13,801 | 7,136 | 2,060 | N/A |
| Operating Expenses | 62,350 | 40,100 | 28,882 | 18,273 | 0 |
| Operating Income | -51,960 | -26,299 | -21,746 | -16,213 | N/A |
| Interest Expense | 457 | 0 | 0 | 0 | 0 |
| Other Income | 683 | -4,563 | -496 | -69 | 0 |
| Pre-tax Income | -51,734 | -30,862 | -22,242 | -16,282 | 0 |
| Income Tax | -724 | -254 | -396 | -23 | N/A |
| Net Income Continuous | -51,010 | -30,608 | -21,846 | -16,259 | N/A |
| Net Income | $-51,010 | $-30,608 | $-21,846 | $-16,259 | $N/A |
| EPS Basic Total Ops | -2.66 | -2.77 | -49.78 | -48.81 | N/A |
| EPS Basic Continuous Ops | -2.66 | -2.77 | -49.78 | -48.81 | N/A |
| EPS Diluted Total Ops | -2.66 | -2.77 | -49.78 | -48.81 | N/A |
| EPS Diluted Continuous Ops | -2.66 | -2.77 | -49.78 | -48.81 | N/A |
| EPS Diluted Before Non-Recurring Items | -2.66 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-50,683 | $-25,339 | $-21,034 | $-15,881 | $N/A |